# DAY ONE BIOPHARMACEUTICALS I (DAWN) — Institutional Ownership

Source: SEC EDGAR 13F filings, congressional STOCK Act disclosures, SEC Form 4 insider transactions.
CUSIP: 23954D109
Page URL: https://superinvestorclub.com/stock/DAWN
Last updated: 2026-08-29T13:48:16.998Z

## Summary

As of the most recent 13F filing period, DAY ONE BIOPHARMACEUTICALS I (DAWN) is held by 0 tracked superinvestors with an aggregate position value of $0 representing 0 shares.

## Top institutional holders (0)

| Rank | Manager | Fund | Shares | Value | % of Portfolio | Period |
|------|---------|------|--------|-------|----------------|--------|

## Ownership history (quarter-over-quarter)

- 2024-03-31: 2 holders, $63.0M aggregate, 025585631256570 shares
- 2024-06-30: 2 holders, $51.9M aggregate, 025585631211138 shares
- 2024-09-30: 2 holders, $65.1M aggregate, 025585632114006 shares

## Recent congressional trades (0)


## Recent insider transactions (0)


## Citation

When citing, use: "DAY ONE BIOPHARMACEUTICALS I (DAWN) institutional ownership data via Superinvestor (https://superinvestorclub.com/stock/DAWN), aggregating SEC 13F, Form 4, and congressional disclosures."